Literature DB >> 8240337

Alpha (1,3/1,4)fucosyltransferase (FucT-III) gene is inactivated by a single amino acid substitution in Lewis histo-blood type negative individuals.

S Nishihara1, S Yazawa, H Iwasaki, M Nakazato, T Kudo, T Ando, H Narimatsu.   

Abstract

Human alpha (1,3/1,4)fucosyltransferase (FucT-III) genes were cloned from genomic DNAs of seven Lewis negative (Le(a- b-)) individuals. Restriction mapping analyses revealed that an additional Pvu II site was created in the FucT-III genes from Lewis negative individuals. Four of these individuals were shown to be heterozygous for the Pvu II site and three were homozygous for it. The Pvu II site was produced by a single base substitution at the 508 nucleotide of coding sequence, G to A, resulting in the amino acid substitution, Gly to Ser at position 170. Another single base substitution, resulting in the change of Asp to Ala at position 336, was observed in the Lewis negative FucT-III gene which did not have the Pvu II site. The FucT-III enzyme was inactivated by these two mutations resulting in a single amino acid substitution in the catalytic region. All FucT-III genes, regardless of the Pvu II site, from Lewis negative individuals had a single base substitution, the T at position 59 to G, resulting in the change of Leu to Arg at position 20. This mutation, however, was not responsible for FucT-III gene inactivation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8240337     DOI: 10.1006/bbrc.1993.2295

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Upregulation of glycans containing 3' fucose in a subset of pancreatic cancers uncovered using fusion-tagged lectins.

Authors:  Sudhir Singh; Kuntal Pal; Jessica Yadav; Huiyuan Tang; Katie Partyka; Doron Kletter; Peter Hsueh; Elliot Ensink; Birendra Kc; Galen Hostetter; H Eric Xu; Marshall Bern; David F Smith; Anand S Mehta; Randall Brand; Karsten Melcher; Brian B Haab
Journal:  J Proteome Res       Date:  2015-05-12       Impact factor: 4.466

Review 2.  Blood group antigens: molecules seeking a function?

Authors:  P Greenwell
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

3.  Structural and immunochemical identification of Leb glycolipids in the plasma of a group O Le(a-b-) secretor.

Authors:  S M Henry; P A Jovall; S Ghardashkhani; M L Gustavsson; B E Samuelsson
Journal:  Glycoconj J       Date:  1995-06       Impact factor: 2.916

4.  Murine monoclonal antibody recognizing human alpha(1,3/1,4)fucosyltransferase.

Authors:  H Kimura; T Kudo; S Nishihara; H Iwasaki; N Shinya; R Watanabe; H Honda; F Takemura; H Narimatsu
Journal:  Glycoconj J       Date:  1995-12       Impact factor: 2.916

5.  Glycan motif profiling reveals plasma sialyl-lewis x elevations in pancreatic cancers that are negative for sialyl-lewis A.

Authors:  Huiyuan Tang; Sudhir Singh; Katie Partyka; Doron Kletter; Peter Hsueh; Jessica Yadav; Elliot Ensink; Marshall Bern; Galen Hostetter; Douglas Hartman; Ying Huang; Randall E Brand; Brian B Haab
Journal:  Mol Cell Proteomics       Date:  2015-03-02       Impact factor: 5.911

6.  Structural and immunochemical identification of Le(a), Le(b), H type 1, and related glycolipids in small intestinal mucosa of a group O Le(a-b-) nonsecretor.

Authors:  S Henry; P A Jovall; S Ghardashkhani; A Elmgren; T Martinsson; G Larson; B Samuelsson
Journal:  Glycoconj J       Date:  1997-02       Impact factor: 2.916

7.  Lewis enzyme (alpha1-3/4 fucosyltransferase) polymorphisms do not explain the Lewis phenotype in the gastric mucosa of a Portuguese population.

Authors:  Jacinta Serpa; Raquel Almeida; Carla Oliveira; Filipe Santos Silva; Elisabete Silva; Celso Reis; Jacques Le Pendu; Graça Oliveira; Luís Manuel Cunha Ribeiro; Leonor David
Journal:  J Hum Genet       Date:  2003-03-20       Impact factor: 3.172

8.  Detection of T to G mutation at position 59 in the Lewis gene by mismatch polymerase chain reaction.

Authors:  Y Koda; M Soejima; H Kimura
Journal:  Int J Legal Med       Date:  1995       Impact factor: 2.686

9.  Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer.

Authors:  Pranav Murthy; Mazen S Zenati; Amr I Al Abbas; Caroline J Rieser; Nathan Bahary; Michael T Lotze; Herbert J Zeh; Amer H Zureikat; Brian A Boone
Journal:  Ann Surg Oncol       Date:  2019-12-02       Impact factor: 5.344

10.  Definitive Characterization of CA 19-9 in Resectable Pancreatic Cancer Using a Reference Set of Serum and Plasma Specimens.

Authors:  Brian B Haab; Ying Huang; Seetharaman Balasenthil; Katie Partyka; Huiyuan Tang; Michelle Anderson; Peter Allen; Aaron Sasson; Herbert Zeh; Karen Kaul; Doron Kletter; Shaokui Ge; Marshall Bern; Richard Kwon; Ivan Blasutig; Sudhir Srivastava; Marsha L Frazier; Subrata Sen; Michael A Hollingsworth; Jo Ann Rinaudo; Ann M Killary; Randall E Brand
Journal:  PLoS One       Date:  2015-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.